Publications
Mason H, Collins M, McHugh N, Godwin J, van Exel J, Donaldson C and Baker R (2018). Is “end of life” a special case? Connecting Q with survey methods to measure societal support for views on the value of life‐extending treatments. Health Economics (early view).
Link to open access paper: http://onlinelibrary.wiley.com/doi/10.1002/hec.3640/full
McHugh N, van Exel J, Mason H, Godwin J, Collins M, Donaldson C, Baker R (2018). Are life-extending treatments for terminal illnesses a special case? Exploring choices and societal viewpoints. Social Science and Medicine. 198:61-69 doi.org/10.1016/j.socscimed.2017.12.019
Link to open access paper: https://doi.org/10.1016/j.socscimed.2017.12.019
McHugh N, Baker R, Mason H, Williamson L, van Exel NJA, Deogaonkar R, Collins M, Donaldson C (2015) Extending life for people with a terminal illness: a moral right and an expensive death? Exploring societal perspectives BMC Medical Ethics 16:14.
Open access link: http://www.biomedcentral.com/1472-6939/16/14
Media
Baker R, Mason H, McHugh N (2018) UK spends generously to extend lives of people with terminal illnesses – against the public’s wishes. The Conversation, online.
Rohan Deogaonkar, Rachel Baker, Helen Mason, Neil McHugh, and Marissa Collins (2016) Eliciting Societal Views on the Value of Life-Extending Treatments Using Q Methodology in Round J Care at the End of Life - An Economic Perspective. Springer International Publishing. London.
http://link.springer.com/chapter/10.1007/978-3-319-28267-1_10
Christel Protiere, Rachel Baker ,Dominique Genre, Anthony Goncalves, Patrice Viens (2017) Marketing authorization procedures for advanced cancer drugs: exploring the views of patients, oncologists, healthcare decision makers and citizens in France Medical Decision Making 37,5: 555-566
Sofie Wouters, Job van Exel, Rachel Baker, Werner Brower (2017) Priority to end of life treatments? Views of the public in the Netherlands Value in Health 20,1: 107–117
Jose-Luis Pinto-Prades, Fernando-Ignacio Sánchez-Martínez, Belen Corbacho, Rachel Baker (2014) Valuing QALYS at the End of Life Social Science & Medicine 113: 5-14
Mark Pennington, Rachel Baker, Werner Brouwer, Helen Mason, Dorte Gyrd Hansen, Angela Robinson, Cam Donaldson and the EuroVaQ Team (2015) Comparing WTP values of different types of QALY gain elicited from the general public Health Economics 24, 3: 280-293
Mason H, Collins M, McHugh N, Godwin J, van Exel J, Donaldson C and Baker R (2018). Is “end of life” a special case? Connecting Q with survey methods to measure societal support for views on the value of life‐extending treatments. Health Economics (early view).
Link to open access paper: http://onlinelibrary.wiley.com/doi/10.1002/hec.3640/full
McHugh N, van Exel J, Mason H, Godwin J, Collins M, Donaldson C, Baker R (2018). Are life-extending treatments for terminal illnesses a special case? Exploring choices and societal viewpoints. Social Science and Medicine. 198:61-69 doi.org/10.1016/j.socscimed.2017.12.019
Link to open access paper: https://doi.org/10.1016/j.socscimed.2017.12.019
McHugh N, Baker R, Mason H, Williamson L, van Exel NJA, Deogaonkar R, Collins M, Donaldson C (2015) Extending life for people with a terminal illness: a moral right and an expensive death? Exploring societal perspectives BMC Medical Ethics 16:14.
Open access link: http://www.biomedcentral.com/1472-6939/16/14
Media
Baker R, Mason H, McHugh N (2018) UK spends generously to extend lives of people with terminal illnesses – against the public’s wishes. The Conversation, online.
Rohan Deogaonkar, Rachel Baker, Helen Mason, Neil McHugh, and Marissa Collins (2016) Eliciting Societal Views on the Value of Life-Extending Treatments Using Q Methodology in Round J Care at the End of Life - An Economic Perspective. Springer International Publishing. London.
http://link.springer.com/chapter/10.1007/978-3-319-28267-1_10
Christel Protiere, Rachel Baker ,Dominique Genre, Anthony Goncalves, Patrice Viens (2017) Marketing authorization procedures for advanced cancer drugs: exploring the views of patients, oncologists, healthcare decision makers and citizens in France Medical Decision Making 37,5: 555-566
Sofie Wouters, Job van Exel, Rachel Baker, Werner Brower (2017) Priority to end of life treatments? Views of the public in the Netherlands Value in Health 20,1: 107–117
Jose-Luis Pinto-Prades, Fernando-Ignacio Sánchez-Martínez, Belen Corbacho, Rachel Baker (2014) Valuing QALYS at the End of Life Social Science & Medicine 113: 5-14
Mark Pennington, Rachel Baker, Werner Brouwer, Helen Mason, Dorte Gyrd Hansen, Angela Robinson, Cam Donaldson and the EuroVaQ Team (2015) Comparing WTP values of different types of QALY gain elicited from the general public Health Economics 24, 3: 280-293